Pulsed Light Medical Technology (PLMT) is revolutionizing the treatment of peripheral neuropathy (PN), offering significant advantages over traditional Red Light Therapy (RLT) and Near-Infrared (NIR) therapies. While standard RLT/NIR systems typically use a single wavelength, PLMT employs a polychromatic approach, emitting multiple wavelengths simultaneously. This innovative design allows for a broader spectrum of therapeutic benefits, making PLMT particularly effective in addressing the complex nature of various types of peripheral neuropathy. The efficacy of PLMT in managing PN symptoms stems from its ability to enhance mitochondrial function, reduce inflammation, and promote neuronal survival. By improving ATP production in mitochondrial cells, PLMT facilitates cellular energy and repair processes, leading to reduced neuroinflammation and protection of damaged nerves. Patients often experience relief from pain, tingling, and other PN-related symptoms (Argenta et al., 2017).

Compared to standard RLT/NIR devices, PLMT's multi-wavelength capability enables deeper tissue penetration and a more comprehensive treatment approach. Research has shown that specific wavelengths can target particular issues like inflammation or pain management, making PLMT superior for conditions such as chemotherapy-induced peripheral neuropathy (Joy et al., 2022). Studies indicate that polychromatic light therapy can significantly reduce symptoms and improve quality of life for patients with chemotherapy-induced neuropathy (Argenta et al., 2016).

PBM through PLMT benefits peripheral neuropathy through several mechanisms, including enhanced blood flow, reduced oxidative stress, and improved cellular communication. Increased blood flow aids in delivering essential nutrients and oxygen to damaged nerves, promoting healing. The reduction of oxidative stress diminishes cellular damage, allowing for better nerve function and regeneration (de Andrade et al., 2016).

The innovative PLMT devices from Neurocare Pro offer significant advantages over traditional RLT/NIR systems. By employing a polychromatic approach, PLMT effectively addresses the multifaceted nature of peripheral neuropathy, helping patients manage pain, reduce inflammation, and promote nerve healing. This advanced technology represents a promising complementary treatment for those suffering from various forms of peripheral neuropathy, offering hope for improved symptom management and enhanced quality of life.

The Benefits

Pulsed Light Medical Technology (PLMT) offers key advantages over standard red light therapy (RLT) and near-infrared (NIR) therapy for treating peripheral neuropathy (PN). PLMT's unique features, especially its ability to emit multiple wavelengths, make it more effective for managing PN symptoms. Here are the main benefits and supporting research:

1. Multiple Wavelengths:   PLMT uses a system that emits several wavelengths at once, allowing it to target more biological processes than standard RLT/NIR devices that use just one wavelength. This versatility leads to more thorough treatment of damaged nerves.

Research Support: Argenta et al. (2016) showed that using multiple wavelengths significantly reduced chemotherapy-induced peripheral neuropathy symptoms, highlighting the benefits of this approach.

2. Better Mitochondrial Function: PLMT boosts mitochondrial function by increasing ATP production, which is crucial for cell energy and repair. This improved mitochondrial activity helps nerve regeneration and overall nerve health.

Research Support: Argenta et al. (2017) found that light therapy like PLMT enhances mitochondrial function, which is vital for managing nerve injuries and promoting recovery in PN patients.

3. Less Inflammation: PLMT effectively reduces both body-wide and nerve-specific inflammation, which often contribute to peripheral neuropathy. By tackling inflammation, PLMT can ease neuropathic pain and boost healing.

Research Support: de Andrade et al. (2016) reported that low-level laser therapy, a type of PLMT, lowers inflammation markers, supporting nerve repair and improving neuropathy symptoms.

4, Improved Nerve Healing and Protection: PLMT promotes nerve cell survival and healing, helping protect damaged nerves from further harm. This is especially helpful for patients recovering from chemotherapy or other treatments that can damage nerves.

Research Support: A study by Joy et al. (2022) showed that photobiomodulation effectively promotes nerve repair, suggesting that PLMT is particularly beneficial for patients with various types of peripheral neuropathy.

5. Pain Relief and Symptom Management: Patients using PLMT often report significant reductions in pain and other neuropathy symptoms like tingling and numbness. The multi-wavelength approach allows for targeted treatment of pain pathways.

Research Support: A review by Argenta et al. (2016) found that light therapy, including PLMT, effectively managed pain and improved quality of life in neuropathy patients, especially those affected by chemotherapy.

6. Comfortable and Safe Treatment: PLMT devices typically produce less heat, offering a more comfortable experience compared to standard red light therapy devices. This allows for longer treatment sessions without discomfort.

Research Support: Argenta et al. (2017) highlighted the improved comfort and safety of modern photobiomodulation devices, leading to better adherence to treatment plans.

By offering these benefits, PLMT represents a significant advance in treating peripheral neuropathy compared to standard RLT/NIR therapy. Its ability to address multiple aspects of nerve health and repair makes it a promising option for doctors, practitioners, and patients seeking effective PN management strategies.

The innovative design of PLMT devices from Neurocare Pro, offers significant advantages over traditional red light therapy systems. By using multiple wavelengths, Neurocare Pro’s Elite PLMT systems will deliver optimal relief and address the complex nature of peripheral neuropathy more effectively - managing pain, reducing inflammation, promoting nerve healing, and providing an accelerated comprehensive approach to treating peripheral neuropathy that goes beyond standard red light therapy.

And the best part? Neurocare Pro Systems are an FDA Cleared Class II Medical device, ensuring it as a safe, non-invasive, and painless treatment option, tested for accuracy and performance. Many of NeuroCarePro’s devices are available for home use, allowing you to indulge in self-care sessions from the comfort of your own space. Remember, consistency is key! Unlock its full potential for a life less burdened by neuropathy.

Provide your patients with the most advanced, powerful, and wide-coverage boot system available in the market. The Thigh-High 442 and Calf-High 364 boots are compatible with both the Neurocare Pro 6 port controller and the Neurocare Pro 2 port controller.

They are equipped with advanced firmware, two backlit displays, and offer versatile preset pulse rates for treating any part of the body. These boots are exceptionally potent, necessitating an 18V power source, in contrast to the 14V used by most other boots on the market.

Visit our products page or contact us for assistance.

References and Further Reading:

These resources offer valuable insights into the potential of Pulsed Light Medical Technology (PLMT) and red light therapy for managing various forms of neuropathy, including chemotherapy-induced and diabetic peripheral neuropathy. They highlight the advantages of PLMT over standard red light therapy, supporting Neurocare Pro Products' innovative approach to neuropathy treatment.

• National Institutes of Health on Low-level light therapy/photobiomodulation for diabetic peripheral neuropathy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476114/.
• MedSpace article on light therapy's potential for chemotherapy-induced neuropathy: Link to MedSpace article
• Dr. Courtney Conley's insights on red light therapy for foot neuropathy: Link to Gait Happens article
• Joy L, et al. (2022). Photobiomodulation therapy for preventing chemotherapy-induced peripheral neuropathy: NEUROLASER trial results. Support Care Cancer, 30(6):5509-5517. PubMed Central link
• Argenta PA, Ballman KV, Geller MA, Carson LF, Ghebre R, Mullany SA, Teoh DG, Winterhoff BJ, Rivard CL, Erickson BK. The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial. Gynecol Oncol. 2017 Jan;144(1):159-166. doi: 10.1016/j.ygyno.2016.11.013. Epub 2016 Nov 22. PMID: 27887804. Accessed from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6027218/
• Argenta PA, Ballman KV, Geller MA, Carson LF, Ghebre R, Mullany SA, Teoh DG, Winterhoff BJ, Rivard CL, Erickson BK. The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial. Gynecol Oncol. 2017 Jan;144(1):159-166. doi: 10.1016/j.ygyno.2016.11.013. Epub 2016 Nov 22. PMID: 27887804. Accessed from: https://pubmed.ncbi.nlm.nih.gov/27887804/
• Ana Laura Martins de Andrade, Paulo Ségio Bossini, Nivaldo Antônio Parizotto. Use of low level laser therapy to control neuropathic pain: A systematic review,
  Journal of Photochemistry and Photobiology B: Biology, Volume 164, 2016, Pages 36-42, ISSN 1011-1344, https://doi.org/10.1016/j.jphotobiol.2016.08.025.
  Accessed from: https://www.sciencedirect.com/science/article/pii/S1011134416304456
• National Institutes of Health on Low-level light therapy/photobiomodulation for diabetic peripheral neuropathy: NIH article link